Skip to content
2000
Volume 21, Issue 4
  • ISSN: 1389-2037
  • E-ISSN: 1875-5550

Abstract

Contact lens wear is generally safe and provides excellent vision. However, contact lens wear is often associated with the risk of developing ocular surface infection and inflammation, and in severe cases, the infection can result in loss of vision. Antimicrobial peptide-coated contact lenses have been made to help reduce the incidence of infection and inflammation. This paper reviews the research progress from conception, through the laboratory and preclinical tests to the latest information on clinical testing of an antimicrobial contact lens. We provide insights into the pathways followed and pitfalls that have been encountered. The journey has not always been linear or smooth, but has resulted in some of the first published clinical testing of antimicrobial peptide-coated contact lenses in humans. We hope this may help lead to the development and commercialisation of antimicrobial contact lenses in the future.

Loading

Article metrics loading...

/content/journals/cpps/10.2174/1389203720666190820152508
2020-03-01
2025-09-04
Loading full text...

Full text loading...

/content/journals/cpps/10.2174/1389203720666190820152508
Loading

  • Article Type:
    Review Article
Keyword(s): antimicrobial peptide; clinical trial; Contact lens; keratitis; MeL4; melamine
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test